Company Chemclin Diagnostics Co., Ltd.

Equities

688468

CNE100005311

Medical Equipment, Supplies & Distribution

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sector Diagnostic & Testing Substances

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 15/05/2024 BST			5-day change	1st Jan Change
7.57 ^CNY	+0.53%		-4.78%	-29.84%

05-03	Chemclin Diagnostics Launches Homegrown Immunodetection Kits	MT
04-29	Chemclin Diagnostics Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Chemclin Diagnostics Co Ltd is a China-based company mainly engaged in the research and development of clinical immuno chemiluminescence diagnostic test reagents and instruments. The Company's products are LiCA series of diagnostic reagents based on light-induced chemiluminescence and Chemclin series of diagnostic reagents and instruments based on enzymatic chemiluminescence, which are mainly used in infectious diseases (such as hepatitis B, hepatitis C, Acquired Immunodeficiency Syndrome, syphilis, hepatitis A, hepatitis E) detection of markers, tumor markers, thyroid hormones, reproductive endocrine hormones, diabetes, myocardial markers and inflammation. The Company mainly operates its businesses in the domestic market.

Number of employees: 690

CNY in Million	2022	Weight	2023	Weight	Delta
In Vitro Diagnostic Reagents 100.0 %	465	100.0 %	445	100.0 %	-4.28%

CNY in Million	2022	Weight	2023	Weight	Delta
China 100.0 %	465	100.0 %	445	100.0 %	-4.28%

Managers	Title	Age	Since
Lin Li CEO	Chief Executive Officer	62	31/12/07
Yan Ling Huang DFI	Director of Finance/CFO	49	31/12/07
Hong Yan Pu BRD	Director/Board Member	50	31/12/06
Zheng Ming Huang BRD	Director/Board Member	54	31/12/09

Members of the board	Title	Age	Since
Jun Jie Zhang BRD	Director/Board Member	47	10/09/19
Jie Zhang BRD	Director/Board Member	71	23/10/19
Lin Li CEO	Chief Executive Officer	62	31/12/07
Na Sun BRD	Director/Board Member	46	23/10/19
Ren Qian Zhong BRD	Director/Board Member	62	23/10/19
Qi Zhou BRD	Director/Board Member	53	10/09/19
Hong Yan Pu BRD	Director/Board Member	50	31/12/06
Yan Ling Huang DFI	Director of Finance/CFO	49	31/12/07
Zi Fu Lian CHM	Chairman	56	05/09/22
Ling Ling Mei BRD	Director/Board Member	42	05/09/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	401,108,000	155,814,164 ( 38.85 %)	0	38.85 %

Name	Equities	%	Valuation
CHINA RENAISSANCE HOLDINGS LIMITED 14.26 %	39,224,454	14.26 %	40 M ¥
Legend Capital Co. Ltd. 10.70 %	29,420,486	10.70 %	30 M ¥
Vision Alliance LLC 6.786 %	18,661,129	6.786 %	19 M ¥
PING AN INSURANCE (GROUP) COMPANY OF CHINA, LTD. 4.884 %	13,429,878	4.884 %	14 M ¥
Shenzhen Pingan Innovation Capital Investment Ltd. 2.407 %	6,620,112	2.407 %	7 M ¥
China Asset Management Co., Ltd. 0.9091 %	2,500,006	0.9091 %	3 M ¥
GF Fund Management Co., Ltd. 0.4491 %	1,235,154	0.4491 %	1 M ¥
Yinhua Fund Management Co., Ltd. 0.3254 %	894,824	0.3254 %	918 116 ¥
HSBC Jintrust Fund Management Co. Ltd. 0.2723 %	748,909	0.2723 %	768 403 ¥
Orient Securities Asset Management Co. Ltd. 0.1667 %	458,393	0.1667 %	470 325 ¥

Chemclin Diagnostics Co., Ltd.

Beike Modern Manufacturing Park 7 Fengxian Middle Road

100094, Beijing

http://www.chemclin.com

address Chemclin Diagnostics Co., Ltd.(688468)

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Diagnostic & Testing Substances

	1st Jan change	Capi.
CHEMCLIN DIAGNOSTICS CO., LTD.	-29.84%	421M
BIOMÉRIEUX	-4.57%	12.33B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-4.35%	8.14B
DIASORIN S.P.A.	+8.91%	5.89B
LANTHEUS HOLDINGS, INC.	+30.81%	5.62B
AUTOBIO DIAGNOSTICS CO., LTD.	-7.42%	4.24B
10X GENOMICS, INC.	-54.27%	3.06B
ANDON HEALTH CO., LTD.	+14.44%	2.76B
VITROLIFE AB	-2.21%	2.41B
MYRIAD GENETICS, INC.	+28.53%	2.23B

Diagnostic & Testing Substances